Drug Database
Back to search

Netherlands· NL-e44b43ee7a8a

Ondansetron Aurobindo 4 mg, filmomhulde tabletten

A ondansetron product containing ondansetronhydrochloride 2-water, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 19 of our 19 countries.

ATC A04AA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOndansetron Aurobindo 4 mg, filmomhul…ATCA04AA01REGISTER NO.NL-e44b43ee7a8aPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ondansetronhydrochloride 2-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ondansetron is registered in 19 of 19 countries.

Countries holding a registration under ATC A04AA01 (ondansetron), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose
Search ondansetron products by name

Ondansetron · ATC A04AA01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ondansetron costs, country by country.

Normalised to the WHO defined daily dose (16 mg), the median price runs from $0.23 in United States to $18.43 in Switzerland — a ×79 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Ondansetron · price per daily dose (16 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$18.43
  • IT Italy$14.68
  • FR France$5.36
  • US United States$0.23 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ONDANSETRONHYDROCHLORIDE 2-WATER
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
A04AA01
ATC class
Ondansetron
Defined daily dose
16 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    105867

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

841 interactions on record for ondansetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ondansetron against other medicinesHow interaction checks work

Ondansetron · interactions on record

841 records

  • 139 severe
  • 240 moderate
  • 6 minor
  • 402 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe

54 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ondansetron in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ondansetron products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ondansan, Ondansan I.V.
  • Belgium · Ondansetron Ab, Ondansetron Accord Healthcare
  • Bulgaria · Zofran, Зондарон
  • Cyprus · Ondansetron Accord, Ondansetron Noridem
  • Czechia · Novetron, Ondansetron Accord
  • Germany · Cellondan, Ondansetron 1 A Pharma
  • Denmark · Ondansetron "kalceks", Ondansetron "stada"
  • Estonia · Ondansetron Accord, Ondansetron Basi
  • Spain · Ondansetrón Accord, Ondansetron Aristo
  • Finland · Ondansetron Accord, Ondansetron Accordpharma
  • France · Ondansetron Accord, Ondansetron Arrow
  • United Kingdom (Northern Ireland) · Ametron Melt, Emistem
  • Greece · Cruzafen, Odasen
  • Croatia · Ondansetron Kalceks, Ondanzetron Kabi
  • Hungary · Emetron, Ondansetron Kabi
  • Ireland · Emizof, Ondansetron Accord Healthcare Ireland
  • Iceland · Cinveron, Ondansetron Bluefish
  • Italy · Emistop, Ondansetron Accord
  • Lithuania · Ondansetron Accord, Ondansetron Basi
  • Luxembourg · Avessaron, Ondansetron B. Braun
  • Latvia · Emetron, Ondansetron Accord
  • Malta · Emytron, Ondansetron Accord Healthcare Ireland
  • Norway · Ondansetron Accord, Ondansetron Accordpharma
  • Poland · Atossa, Ondansetron Accord
  • Portugal · Danevon, Emytron
  • Romania · Ondansetron Aurobindo, Ondansetron Kabi
  • Sweden · Ondansetron Accord, Ondansetron Accordpharma
  • Slovenia · Ondansetron Accord, Ondansetron Baxter
  • Slovakia · Ondansetron Accord, Ondansetron B. Braun

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b79fcbd0-ab48-4f54-b993-0d2929b77118
GET /v1/drugs/b79fcbd0-ab48-4f54-b993-0d2929b77118?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h105867_smpc.pdf",
  "strength": null,
  "atc_label": "Ondansetron",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg105867",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 0-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ONDANSETRONHYDROCHLORIDE 2-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h105867.pdf",
  "authorised_at": "2010/09/27",
  "procedure_number": "NL/H/2677/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "105867",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about ondansetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console